Sign in Create account

GlaxoSmithKline Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: GLAXO BSE: 500660

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter75.00%
  • Mutual funds4.87%
  • FII/FPI4.79%
  • Other DII2.93%
  • Public12.41%

Largest holders

NameCategoryShares %Shares
GLAXO GROUP LIMITEDPromoter35.9900%60970500
GLAXOSMITHKLINE PTE LIMITEDPromoter28.1000%47604024
ESKAYLAB LIMITEDPromoter6.9400%11760000
BURROUGHS WELLCOME INTERNATIONAL LIMITEDPromoter3.9700%6720000
LICI ASM NON PARPublic1.0800%1826540

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 75.00% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 4.62% to 4.79% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 4.73% to 4.87% in Jun 2026 qtr

18 mutual fund schemes also hold this stock.

All shareholding details →

Shareholding Trend (Promoter/FII/DII %, real filed periods only)

HolderJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Latest change
Promoter 75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00% 0.00 pp
FII 4.79%4.62%4.64%4.80%4.89%4.52%4.50%4.36% 0.17 pp
DII 7.80%7.68%7.70%7.75%7.70%7.79%7.30%7.34% 0.12 pp
Mutual funds (within DII) 4.87%4.73%4.77%5.05%5.17%5.17%4.96%4.98% 0.14 pp
Public (non-institutional) 12.41%12.70%12.66%12.45%12.41%12.69%13.20%13.30% -0.29 pp

Public (non-institutional) = SEBI's Public total minus FII minus DII, shown only where all three were filed. A dash means that holder category filed nothing for that quarter. Holder counts are as filed (entities, not schemes).

Shareholding Pattern (latest quarter)

Category% holdingShareholders
Grand Total 100.0000 126087
(A) Promoter & Promoter Group 75.0000 4
(B) Public 25.0000 126083
(C1) Shares underlying DRs 0.0000 0
(C) Non Promoter-Non Public 0.0000 0
(C2) Shares held by Employee Trust 0.0000 0

Mutual fund holdings

18 schemes in our data hold this stock as of July 31, 2026 — weight is the share of each scheme's portfolio. Over 3 months 13 raised and 5 cut the weight. Covers the funds in our feed (about 670 schemes), not every scheme in the market; the feed has no share counts or rupee values.

SchemeWeight in scheme3M change in weight
Tata Aggressive Hybrid Fund(IDCW Payout) 2.13% 2.13 pp
Tata Aggressive Hybrid Fund(M-IDCW Payout) 2.13% 2.13 pp
DSP Quant Fund 2.08% 2.08 pp
DSP Quant Fund(IDCW) 2.08% 2.08 pp
SBI Midcap Fund(IDCW Payout) 1.31% 0.10 pp
Kotak Large & Midcap Fund(IDCW Payout) 0.91% 0.06 pp
Mahindra Manulife ELSS Tax Saver Fund 0.88% -0.03 pp
Mahindra Manulife ELSS Tax Saver Fund(IDCW) 0.88% -0.03 pp
Groww Value Fund(M-IDCW) 0.83% 0.83 pp
Groww Value Fund(Q-IDCW) 0.83% 0.83 pp
Aditya Birla SL Pharma & Healthcare Fund 0.80% -0.05 pp
Aditya Birla SL Pharma & Healthcare Fund(IDCW) 0.80% -0.05 pp
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund 0.64% -0.04 pp
ICICI Pru Smallcap Fund(IDCW Payout) 0.58% 0.05 pp
Motilal Oswal Nifty Midcap 150 Index Fund 0.26% 0.02 pp
ICICI Pru MNC Fund 0.11% 0.04 pp
ICICI Pru MNC Fund(IDCW) 0.11% 0.04 pp
Motilal Oswal Nifty 500 Index Fund 0.05% 0.00 pp

Named Shareholders

Individually-disclosed large holders as of June 30, 2026 -- the filing only names holders large/notable enough to be individually disclosed, not every real shareholder.

NameCategory% holdingShares
GLAXO GROUP LIMITED Promoter · Overseas Corporate Bodies 35.9900 60970500
GLAXOSMITHKLINE PTE LIMITED Promoter · Overseas Corporate Bodies 28.1000 47604024
ESKAYLAB LIMITED Promoter · Overseas Corporate Bodies 6.9400 11760000
BURROUGHS WELLCOME INTERNATIONAL LIMITED Promoter · Overseas Corporate Bodies 3.9700 6720000
LICI ASM NON PAR Public · Insurance Companies 1.0800 1826540

Related

Bulk & block deals Insider trading & SAST